SOYO yields 200000000.00% · PFE yields 6.20%● Live data
📍 SOYO pulled ahead of the other in Year 1
Combined, SOYO + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SOYO + PFE for your $10,000?
Soyo Group, Inc. distributes consumer electronics and computer products. Its consumer electronics include a line of LCD display televisions and monitors, as well as Bluetooth wireless devices; and computer products include a line of designer motherboards and related peripherals for intensive multimedia applications, corporate alliances, telecommunications, and specialty market requirements. The company also provides bare bone systems, flash memory, and small hard disk drives for corporate and mobile users; and internal multimedia reader/writer and wireless networking solutions products for small office and home office users, as well as hard disk accessories. It offers SOYO brands of products in the United States, Canada, and Latin America. Its brands include Prive, SOYO, Honeywell, and Le Vello, as well as the Honeywell Brand of licensed consumer electronics products. The company also serves its customers in the United Kingdom, Europe, Asia, and South Africa. It offers its product through a network of distributors to resellers, system integrators, and value-added resellers, as well as through retailers, mail-order catalogs, and e-tailers to consumers. The company is headquartered in Ontario, California.
Full SOYO Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.